Disorders of Potassium Metabolism

Comprehensive Clinical Nephrology: Fourth Edition

Volumn , Issue , 2010, Pages 118-129

  Weiner, I David ^a   Linas, Stuart L ^b   Wingo, Charles S ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882838266     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-05876-6.00009-5     Document Type: Chapter

References (44)

1. Youn JH, McDonough AA Recent advances in understanding integrative control of potassium homeostasis. Annu Rev Physiol 2009, 71:381-401.
2. Rabinowitz L, Aizman RI The central nervous system in potassium homeostasis. Front Neuroendocrinol 1993, 14:1-26.
3. Aizawa H, Morita K, Minami H, et al. Exertional rhabdomyolysis as a result of strenuous military training. J Neurol Sci 1995, 132:239-240.
4. Milton AE, Weiner ID Intracellular pH regulation in the rabbit cortical collecting duct A-type intercalated cell. Am J Physiol 1997, 273:F340-F347.
5. Hamm LL, Gillespie C, Klahr S NH4Cl inhibition of transport in the rabbit cortical collecting tubule. Am J Physiol 1985, 248:F631-F637.
6. Bloomfield RL, Wilson DJ, Buckalew VM The incidence of diuretic-induced hypokalemia in two distinct clinic settings. J Clin Hypertens 1986, 2:331-338.
7. Barri YM, Wingo CS The effects of potassium depletion and supplementation on blood pressure: a clinical review. Am J Med Sci 1997, 314:37-40.
8. Huang CL, Kuo E Mechanisms of disease: WNK-ing at the mechanism of salt-sensitive hypertension. Nat Clin Pract Nephrol 2007, 3:623-630.
9. Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994, 330:1852-1857.
10. Knochel JP Diuretic-induced hypokalemia. Am J Med 1984, 77:18-27.
11. Reungjui S, Pratipanawatr T, Johnson RJ, et al. Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia. Curr Opin Nephrol Hypertens 2008, 17:470-476.
12. Shafi T, Appel LJ, Miller ER, et al. Changes in serum potassium mediate thiazide-induced diabetes. Hypertension 2008, 52:1022-1029.
13. Singhal PC, Abramovici M, Venkatesan J, et al. Hypokalemia and rhabdomyolysis. Miner Electrolyte Metab 1991, 17:335-339.
14. Ray PE, Suga S, Liu XH, et al. Chronic potassium depletion induces renal injury, salt sensitivity, and hypertension in young rats. Kidney Int 2001, 59:1850-1858.
15. Tizianello A, Garibotto G, Robaudo C, et al. Renal ammoniagenesis in humans with chronic potassium depletion. Kidney Int 1991, 40:772-778.
16. Berl T, Linas SL, Alisenbrye GA, et al. On the mechanism of polyuria in potassium depletion. The role of polydipsia. J Clin Invest 1977, 60:620.
17. Gabuzda GJ, Hall II Relation of potassium depletion to renal ammonium metabolism and hepatic coma. Medicine (Baltimore) 1966, 45:481-489.
18. Ahlawat SK, Sachdev A Hypokalaemic paralysis. Postgrad Med J 1999, 75:193-197.
19. Antes LM, Kujubu DA, Fernandez PC Hypokalemia and the pathology of ion transport molecules. Semin Nephrol 1998, 18:31-45.
20. Knochel JP, Dotin LN, Hamburger RJ Pathophysiology of intense physical conditioning in a hot climate. I. Mechanisms of potassium depletion. J Clin Invest 1972, 51:242-255.
21. Gill MA, DuBe JE, Young WW Hypokalemic, metabolic alkalosis induced by high-dose ampicillin sodium. Am J Hosp Pharm 1977, 34:528-531.
22. O'Regan S, Carson S, Chesney RW, et al. Electrolyte and acid-base disturbances in the management of leukemia. Blood 1977, 49:345-353.
23. Taher SM, Anderson RJ, McCartney R, et al. Renal tubular acidosis associated with toluene "sniffing.". N Engl J Med 1974, 290:765-768.
24. Isnard Bagnis C, Deray G, Baumelou A, et al. Herbs and the kidney. Am J Kidney Dis 2004, 44:1-11.
25. Lifton RP, Dluhy RG, Powers M, et al. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992, 355:262-265.
26. White PC, New MI, Dupont B Congenital adrenal hyperplasia. II. N Engl J Med 1987, 316:1580-1586.
27. Funder JW, Pearce PT, Smith R, et al. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science 1988, 242:583-585.
28. Farese RV, Biglieri EG, Shackleton CH, et al. Licorice-induced hypermineralocorticoidism. N Engl J Med 1991, 325:1223-1227.
29. Ulick S, Wang JZ, Blumenfeld JD, et al. Cortisol inactivation overload: A mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 1992, 74:963-967.
30. Whang R Magnesium deficiency: Pathogenesis, prevalence, and clinical implications. Am J Med 1987, 82:24-29.
31. Seyberth HW An improved terminology and classification of Bartter-like syndromes. Nat Clin Pract Nephrol 2008, 4:560-567.
32. Riveira-Munoz E, Chang Q, Bindels RJ, et al. Gitelman's syndrome: Towards genotype-phenotype correlations?. Pediatr Nephrol 2007, 22:326-332.
33. Schild L, Canessa CM, Shimkets RA, et al. A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system. Proc Natl Acad Sci USA 1995, 92:5699-5703.
34. Kruse JA, Carlson RW Rapid correction of hypokalemia using concentrated intravenous potassium chloride infusions. Arch Intern Med 1990, 150:613-617.
35. Kunin AS, Surawicz B, Sims EA Decrease in serum potassium concentration and appearance of cardiac arrhythmias during infusion of potassium with glucose in potassium depleted patients. N Engl J Med 1962, 266:288.
36. Batlle DC, Arruda JA, Kurtzman NA Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. N Engl J Med 1981, 304:373-380.
37. Kimura H, Mujais SK Cortical collecting duct Na-K pump in obstructive nephropathy. Am J Physiol 1990, 258:F1320-F1327.
38. Gordon RD Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension 1986, 8:93-102.
39. Wilson FH, Disse-Nicodème S, Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science 2001, 293:1107-1112.
40. Allon M Hyperkalemia in end-stage renal disease: Mechanisms and management. J Am Soc Nephrol 1995, 6:1134-1142.
41. Allon M, Dunlay R, Copkney C Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med 1989, 110:426-429.
42. Sebastian A, Schambelan M, Sutton JM Amelioration of hyperchloremic acidosis with furosemide therapy in patients with chronic renal insufficiency and type 4 renal tubular acidosis. Am J Nephrol 1984, 4:287-300.
43. Gerstman BB, Kirkman R, Platt R Intestinal necrosis associated with postoperative orally administered sodium polystyrene sulfonate in sorbitol. Am J Kidney Dis 1992, 20:159-161.
44. Smith TW, Butler VP, Haber E, et al. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: Experience in 26 cases. N Engl J Med 1982, 307:1357-1362.